CUTL2 Antibody (CL14332) - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26842
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Rat (95%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2B Clone # CL14332
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
This antibody was developed using a synthetic peptide derived from O14529, with the exact immunogen sequence remaining proprietary.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Scientific Data Images for CUTL2 Antibody (CL14332) - BSA Free
Immunocytochemistry/ Immunofluorescence: CUTL2 Antibody (CL14332) [NBP3-26842]
Staining in SH-SY5Y cell line showing specific staining of nucleoplasm in green. Microtubule and nuclear probes are visualized in red and blue respectively (where available).Applications for CUTL2 Antibody (CL14332) - BSA Free
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
2-10 ug/ml
Application Notes
ICC/IF Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, pH 7.2, 40% glycerol
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CUTL2
Alternate Names
CDP2, CUTL2, cut-like 2 (Drosophila), cut-like homeobox 2, homeobox protein cut-like 2, Homeobox protein cux-2, KIAA0293
Gene Symbol
CUX2
Additional CUTL2 Products
Product Documents for CUTL2 Antibody (CL14332) - BSA Free
Product Specific Notices for CUTL2 Antibody (CL14332) - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...